Podcast
Questions and Answers
What is the primary goal of this study?
What is the primary goal of this study?
- To assess the proportion of participants achieving HbA1c less than 7.0%
- To compare the efficacy, safety, and tolerability of combination therapy of dapagliflozin plus linagliptin versus dapagliflozin plus vildagliptin as add-on therapy (correct)
- To evaluate the effect of metformin on body weight
- To compare the efficacy of linagliptin and vildagliptin as monotherapy
How many participants were randomly assigned in this study?
How many participants were randomly assigned in this study?
- 236 participants (correct)
- 100 participants
- 200 participants
- 300 participants
What is the primary outcome measured in this study?
What is the primary outcome measured in this study?
- Mean change in postprandial blood glucose (PPBG)
- Mean change in fasting blood glucose (FBG)
- Mean change in hemoglobin A1c (HbA1c) from baseline to the end of week 16 (correct)
- Proportion of participants achieving HbA1c less than 7.0%
What is the duration of this study?
What is the duration of this study?
What is the dose of dapagliflozin used in this study?
What is the dose of dapagliflozin used in this study?
What is the key secondary endpoint measured in this study?
What is the key secondary endpoint measured in this study?
What is the difference in mean reduction of HbA1c between the dapagliflozin/linagliptin and dapagliflozin/vildagliptin groups?
What is the difference in mean reduction of HbA1c between the dapagliflozin/linagliptin and dapagliflozin/vildagliptin groups?
What is the dose of vildagliptin used in this study?
What is the dose of vildagliptin used in this study?
What type of diabetes patients are enrolled in this study?
What type of diabetes patients are enrolled in this study?
What is the treatment that participants received in addition to metformin?
What is the treatment that participants received in addition to metformin?
Flashcards are hidden until you start studying